Literature DB >> 1586718

B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines.

M Arsura1, M Introna, F Passerini, A Mantovani, J Golay.   

Abstract

The B-myb gene is highly homologous to the c-myb protooncogene in several domains and also shares some of the functions of c-myb in that it can act as a transcriptional activator. In addition, the expression of both the B-myb and c-myb genes correlates with proliferation of normal hematopoietic cells. We investigated more directly the role of B-myb in proliferation of hematopoietic cell lines using B-myb-specific antisense oligonucleotides. We showed that several anti-B-myb oligonucleotides, complementary to distinct regions of the gene, inhibit significantly and in a dose-dependent manner the proliferation of all myeloid or lymphoid cell lines tested. This block in proliferation was not accompanied by detectable differentiation of U937 or HL60 cells to macrophages or granulocytes either spontaneously or after exposure to chemical agents. These data suggest that the B-myb gene, like c-myb, is necessary for hematopoietic cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586718

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.

Authors:  Xiaolin Li; Donald P McDonnell
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin).

Authors:  L Caveda; I Martin-Padura; P Navarro; F Breviario; M Corada; D Gulino; M G Lampugnani; E Dejana
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

3.  Activation of human B-MYB by cyclins.

Authors:  A Sala; M Kundu; I Casella; A Engelhard; B Calabretta; L Grasso; M G Paggi; A Giordano; R J Watson; K Khalili; C Peschle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

4.  Mybl2, downregulated during colon epithelial cell maturation, is suppressed by miR-365.

Authors:  Michael Papetti; Leonard H Augenlicht
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-07-07       Impact factor: 4.052

5.  Downregulation of B-myb promotes senescence via the ROS-mediated p53/p21 pathway, in vascular endothelial cells.

Authors:  Zhihui Zhou; Yanlin Yin; Qun Chang; Guanqun Sun; Jiahui Lin; Yalei Dai
Journal:  Cell Prolif       Date:  2016-11-23       Impact factor: 6.831

6.  Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules.

Authors:  V Facchinetti; L Loffarelli; S Schreek; M Oelgeschläger; B Lüscher; M Introna; J Golay
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

7.  B-myb is a gene implicated in cell cycle and proliferation of breast cancer.

Authors:  Deyou Tao; Yihong Pan; Hongsheng Lu; Song Zheng; Hui Lin; Hongyan Fang; Feilin Cao
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

8.  Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements.

Authors:  T Rozovskaia; O Ravid-Amir; S Tillib; G Getz; E Feinstein; H Agrawal; A Nagler; E F Rappaport; I Issaeva; Y Matsuo; U R Kees; T Lapidot; F Lo Coco; R Foa; A Mazo; T Nakamura; C M Croce; G Cimino; E Domany; E Canaani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-02       Impact factor: 11.205

9.  The carboxyterminus of human c-myb protein stimulates activated transcription in trans.

Authors:  G Vorbrueggen; F Kalkbrenner; S Guehmann; K Moelling
Journal:  Nucleic Acids Res       Date:  1994-07-11       Impact factor: 16.971

10.  Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest.

Authors:  D Lin; M Fiscella; P M O'Connor; J Jackman; M Chen; L L Luo; A Sala; S Travali; E Appella; W E Mercer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.